EXC


Also found in: Dictionary, Encyclopedia, Wikipedia.
AcronymDefinition
EXCException
EXCExcellent Condition
EXCExclusion Dictionary
EXCExchange Component
EXCExcellency
EXCExperiment Computer (US NASA)
EXCElite Xtreme Combat
EXCEnduro Cross Country (motorcycle racing/riding style)
EXCElectronic Cross Connect (Nortel)
References in periodicals archive ?
Due to ring-fencing measures, BGE does not participate in the EXC corporate money pool.
About 0.5 mL ExC was added to 4.5 mL methanolic solution of 2% hydrate aluminum chloride.
Also, Isis remains eligible to receive milestone and royalty payments under its licensing agreement with Excaliard for EXC 001.
As a result of significant utility capex, EXC is expected to grow its rate base at an average annual rate of 7.4% through 2021.
Excluding the USD1.25m payment, Isis Pharmaceuticals Inc is eligible to receive an additional USD8.35m in contingent payments upon achievement of various milestones associated with the clinical and commercial progress of EXC 001, also called PF-06473871.
Its lead product, EXC 001, an antisense oligonucleotide, is developed to interrupt the process of fibrosis by inhibiting expression of connective tissue growth factor (CTGF).
C11 ( NATIVE/COB/TRADITIONAL RIDDEN HORSE EXC 148CM: 1 Norman, J Hunter; 2 Ellie May, M Kent; 3 Junior, H Robinson.
PHI Subsidiaries Improvement: EXC continues to focus on improving the operational and financial performance of the three PHI utility subsidiaries: ACE, DPL, and Pepco.
The US multi-centre studies will assess the efficacy, safety, and tolerability of EXC 001 in two different models to evaluate the improvement of the appearance of scars in subjects undergoing elective abdominoplasty surgery and revision of scars associated with prior breast surgery.
New York: Fitch Ratings has assigned a 'BBB' rating to Exelon Corp.'s (EXC) new $1.8 billion issue of notes to be offered in multiple tranches maturing in five, 10 and 30 years.
Isis Pharmaceuticals Inc, an equity owner of Excaliard, has granted Excaliard an exclusive worldwide license agreement for the development and commercialisation of certain antisense drugs, including EXC 001, Excaliard's lead product.